title: Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression.
abstract: Endochondral ossification is the process of skeletal bone growth via the formation of a cartilage template that subsequently undergoes mineralization to form trabecular bone. Genetic mutations affecting the proliferation or differentiation of chondrocytes result in skeletal abnormalities. Activating transcription factor-2 (ATF-2) modulates expression of cell cycle regulatory genes in chondrocytes, and mutation of ATF-2 results in a dwarfed phenotype. Here we investigate the regulatory role that ATF-2 plays in expression of the pocket proteins, cell cycle regulators important in cellular proliferation and differentiation. The spatial and temporal pattern of pocket protein expression was identified in wild type and mutant growth plates. Expression of retinoblastoma (pRb) mRNA and protein were decreased in ATF-2 mutant primary chondrocytes. pRb mRNA expression was coordinated with chondrogenic differentiation and cell cycle exit in ATDC5 cells. Type X collagen immunohistochemistry was performed to visualize a delay in differentiation in response to loss of ATF-2 signaling. Chondrocyte proliferation was also affected by loss of ATF-2. These studies suggest pRb plays a role in chondrocyte proliferation, differentiation and growth plate development by modulating cell cycle progression. ATF-2 regulates expression of pRb within the developing growth plate, contributing to the skeletal phenotype of ATF-2 mutant mice through the regulation of chondrocyte proliferation and differentiation.
authors.affiliation: Interdisciplinary Program in Biomedical Sciences, Molecular Cell Biology Concentration, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
authors.forename: Dustin S
authors.initials: DS
authors.lastname: Vale-Cruz
authors.forename: Qin
authors.initials: Q
authors.lastname: Ma
authors.forename: Janet
authors.initials: J
authors.lastname: Syme
authors.forename: Phyllis A
authors.initials: PA
authors.lastname: LuValle
mesh_terms: D051698:Activating Transcription Factor 2 / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn; D001846:Bone Development / Q000235:genetics*; D001973:Bromodeoxyuridine / Q000378:metabolism; D002453:Cell Cycle; D002460:Cell Line; D019902:Chondrocytes / Q000166:cytology / Q000378:metabolism; D020219:Chondrogenesis; D024121:Collagen Type X / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D006132:Growth Plate / Q000378:metabolism; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000378:metabolism; D051379:Mice; D009154:Mutation / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D016160:Retinoblastoma Protein / Q000235:genetics* / Q000378:metabolism
chemical_list: D051698:Activating Transcription Factor 2; C497106:Atf2 protein, mouse; D024121:Collagen Type X; D019394:Ki-67 Antigen; D012333:RNA, Messenger; D016160:Retinoblastoma Protein; D001973:Bromodeoxyuridine